# Top 50 Medical Device VC (Venture Capital) Funds in Oceania in October 2023

## Brandon Capital Partners
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 7
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

## Medical Research Commercialisation Fund (MRCF)
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 6
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

## Artesian VC
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 4
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, Information Technology

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

## Pacific Channel
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Medical Device, Medical, Health Care

Investing in great people solving hard problems to create a better future.

## Melbourne Angels
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 4
- Stages: Angel, Seed
- Focus: Biotechnology, Information Technology, Manufacturing

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

## Icehouse Ventures
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Software, SaaS, Information Technology

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

## Cure Kids Ventures
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Medical Device, SaaS, Medical

Investing in innovation for a healthy childhood  
Investing in innovation for a healthy childhood    
About Cure Kids Ventures  
Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to

## Global from Day One
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Software, SaaS, Medical Device

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

## New Zealand Growth Capital Partners
- Type: VC Fund
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Software, SaaS, Manufacturing

The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.

## Uniservices
- Type: VC Fund
- Relevant deals: 3
- Stages: Seed, Pre-Seed
- Focus: Medical Device, SaaS, Audio

Auckland University's commercialisation arm

## Global Health Investment Fund (GHIF)
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Series B, Series C
- Focus: Health Care, Biotechnology, Medical Device

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

## Punakaiki Fund
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, SaaS, Mobile Apps

Punakaiki Fund Limited makes long-term investments into high-growth, revenue-generating New Zealand companies. The company holds 20 investments, $32.3 million in assets, and is raising money in December 2017 for further investment.

## Uniseed Ventures
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Biotechnology, Manufacturing, Health Care

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

## IP Group
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Health Care, Biotechnology, Therapeutics

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

## Flying Kiwis
- Type: VC Fund
- Relevant deals: 2
- Stages: Seed
- Focus: SaaS, 3D Technology, Medical Device

Super-seeded by new entry: Flying Kiwi Angels

## Matū Fund
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 2
- Stages: Seed
- Focus: Biotechnology, Robotics, Nanotechnology

Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.

## K1W1
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Biotechnology, SaaS

K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.

## Regal Funds Management
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Series B, Convertible Note
- Focus: Software, Financial Services, FinTech

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

## South Australian Venture Capital Fund
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, SaaS

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

## Terra Rossa Capital
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical Device

Terra Rossa Capital Pty Ltd operates as a venture capital fund. The Company invests in life science companies. Terra Rossa Capital serves clients in Australia.

## HealthCare Ventures
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.

## Grand Challenges Canada
- Type: VC Fund
- Location: Toronto, Ontario, Canada
- Relevant deals: 1
- Stages: Grant, Seed, Debt Financing
- Focus: Health Care, Medical Device, Biotechnology

Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact® in global health. They are funded by the Government of Canada and they fund innovators in low- and middle-income countries (LMICs) and Canada. The bold ideas they support integrate science and technology, social and business innovation – they call this IntegratedInnovation®. They focus on bringing successful innovation to scale, catalyzing sustainability and impact. They have a determined focus on results, and on saving and improving lives.Grand Challenges Canada works closely with Canada’s International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) and Global Affairs Canada to catalyze scale, sustainability and impact. Grand Challenges Canada takes an evidence-based approach to development innovation to save and improve lives in LMICs. They are a platform for development innovation in Maternal, Newborn and Child Health (MNCH) through their Saving Lives at Birth, Saving Brains and MNCH Stars in Global Health programs. They are also focused on helping the poorest and most vulnerable populations, for example those who suffer from mental illness.Since their launch in 2010, Grand Challenges Canada has supported a pipeline of over 700 projects in more than 80 countries. Their investments are producing results: Thousands of lives have been saved and over two hundred and eighty thousand lives have been improved, thus far. By 2030, these innovations have the potential to save hundreds of thousands of lives and improve millions of lives.

## New Zealand Venture Investment Fund
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 1
- Stages: Seed, Series A, Angel
- Focus: Software, Biotechnology, SaaS

Your guide to finding and using government services.

## Skip Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Software, SaaS, Artificial Intelligence

Skip Capital is a private investment fund investing in technology and infrastructure

## Movac
- Type: VC Fund
- Location: Wellington, Wellington, New Zealand
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, E-Commerce, SaaS

Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.

## Auckland UniServices
- Type: VC Fund
- Location: Perth, Western Australia, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Medical, Marketing, Health Care

Auckland UniServices are experts in commercialisation, intellectual property and early stage investing,Supporting and investing in world-class research, technology as well.

## BridgeLane Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series B
- Focus: Software, Financial Services, Health Care

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

## Brisbane Angels
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Seed, Angel
- Focus: Software, Information Technology, Artificial Intelligence

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

## Bridgewest Group
- Type: VC Fund
- Location: San Diego, California, United States
- Relevant deals: 1
- Stages: Seed
- Focus: Mobile, Hardware, Internet

Bridgewest Group is a closely held investment company with global assets in the biotech, wireless communications, infrastructure for "internet of things," semiconductor, real estate, and financial services industries.

## GD1
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Software, Machine Learning, SaaS

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

## Topcon Healthcare
- Type: VC Fund
- Location: Oakland, New Jersey, United States
- Relevant deals: 1
- Stages: Series A
- Focus: Health Care, Medical Device, Health Diagnostics

Topcon Healthcare empowers providers with advanced imaging, diagnostic solutions and intelligent data technology, offering a more fully integrated approach to diagnosis and treatment in eyecare.

## Playford Capital
- Type: VC Fund
- Location: Adelaide, South Australia, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical Device

Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.

## Transition Level Investments
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: SaaS, Artificial Intelligence, Software

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies.
Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

## Horizons Ventures
- Type: VC Fund
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Artificial Intelligence, Software

Investing in the deep science and technology that can propel humanity towards a radically better future.

## Starfish Ventures
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Software, Enterprise Software, Information Technology

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

## Versant Ventures
- Type: VC Fund
- Location: Menlo Park, California, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

## VU Venture Partners
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Health Care, Machine Learning

A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech

## Dexcom Ventures
- Type: VC Fund
- Location: San Diego, California, United States
- Relevant deals: 1
- Focus: Sensor, Medical, Wearables

The inaugural fund will seek to identify and invest in opportunities to supplement growth in the core business and advance the development of adjacent technologies for the future.

## Breakthrough Victoria
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Quantum Computing, Software, Training

Independent investment company managing the $2 billion Breakthrough Victoria Fund to make Victoria a global innovation leader.

## Powerhouse Ventures
- Type: VC Fund
- Location: Christchurch, Canterbury, New Zealand
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Solar, FinTech, Big Data

powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures

## Microsoft for Startups
- Type: VC Fund
- Location: Redmond, Washington, United States
- Relevant deals: 1
- Stages: Seed, Grant
- Focus: Software, Information Technology, SaaS

Microsoft for Startups is a global program designed to help startups scale with free access to Azure cloud and a streamlined path into selling alongside Microsoft and our vast partner ecosystem.

## CP Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Artificial Intelligence, Machine Learning

CP Ventures is a VC fund that invests internationally in early stage, highly scalable, breakthrough technology companies driven by the 4IR

## Bay Trust
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed
- Focus: Sensor, Hardware, Robotics

Community Trust

## Tuhua Fund
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 1
- Stages: Seed, Series A, Angel
- Focus: Software, Internet, B2B

Micro-Venture Fund investing in 25 Kiwi Startups

## Sydney Angels
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Angel
- Focus: Software, SaaS, Apps

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

## Blackbird Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A, Series B
- Focus: Software, SaaS, Information Technology

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

## UniSA Ventures
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed
- Focus: Software, Health Care, Biotechnology

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

## Enterprise Angels
- Type: VC Fund
- Location: Tauranga, Gisborne, New Zealand
- Relevant deals: 1
- Stages: Seed, Angel
- Focus: Software, Information Technology, Health Care

Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.

## Right Click Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Artificial Intelligence, SaaS

Right Click Capital - Australian Venture Capital Firm

## Victoria University of Wellington
- Type: VC Fund
- Location: Wellington, Wellington, New Zealand
- Relevant deals: 1

A tradition of fostering strong global links in teaching and research and programmes of national significance and international quality.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co